DVAX - Spark Newswire

5 minute read

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs

Today, 5:51 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29)

ACHL

2 minute read

Clover To Procure CpG 1018 Adjuvant From Dynavax For Use In Commercial Production Of Clover’s COVID-19 Vaccine Candidate, SCB-2019 (CpG 1018/Alum)

By Bill Haddad

Today, 5:51 AM

Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum) Pending conditional regulatory approvals, Clover expects to

DVAX

1 minute read

Valneva Concludes Recruitment for COVID-19 Vaccine Candidate Trial

By Vandana Singh

Today, 5:51 AM

Privately-held Valneva SE has completed recruitment for the pivotal Phase 3 trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. VLA2001…

AZN

1 minute read

Uncategorized

Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany

By Vandana Singh

Today, 5:51 AM

Dynavax Technologies Corporation (NASDAQ:DVAX) has entered into a commercialization agreement with Bavarian Nordic for the marketing and distribution of HEPLISAV B,…

DVAX

5 minute read

Uncategorized

64 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:51 AM

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday.

AEI

3 minute read

Uncategorized

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 5:51 AM

CUE

32 minute read

Uncategorized

Earnings Scheduled For May 6, 2021

By Benzinga Insights

Today, 5:51 AM

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.

AAOI